Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to explore the pathogenes, clinical characteristics, laboratory and histological examination results, treatment and prognosis of autoimmune hepatitis(AIH). At phase 1, the investigators focus on studying of the clinical characteristics of acute autoimmune hepatitis, and then will study the difference about treatment effects between acute autoimmune hepatitis and chronic AIH. Morever, the investigators have noticed that drug induced AIH have some special characteristics that may be beneficial to distinguish it with durg induced liver disease. Therefore the investigators will do some studies about drug induced AIH or other disease which maybe related to the onset of AIH.


Clinical Trial Description

Now this study has been researched at phase 1, the investigators focus on studying the difference between acute AIH and chronic AIH. In this phase, the investigators analysed the serum biochemical results such as ALT,AST,IgG,PT,INR and so on, and also compared the histological performance. Finally, we compared the percentages of biochemical remission in the two groups, and the time from initial treatment to biochemical remission has also been put into the analysis. Now, the investigators are preparing for submitting the manuscript of phase 1. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02994537
Study type Observational
Source West China Hospital
Contact Li Yang, MD
Phone +86 18980601276
Email yangli_hx@scu.edu.cn
Status Recruiting
Phase
Start date October 2013
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04617561 - Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II Phase 4
Recruiting NCT04376528 - Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy Phase 4
Not yet recruiting NCT05473403 - Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis N/A
Terminated NCT00286663 - Autoimmune Hepatitis Study Phase 1
Withdrawn NCT03593460 - Phase II AutoImmune Hepatitis Phase 2
Completed NCT03941184 - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Completed NCT01980745 - CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS Phase 4
Recruiting NCT03146884 - Swiss Autoimmune Hepatitis Cohort Study
Recruiting NCT02997878 - Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH Phase 1/Phase 2
Recruiting NCT02936596 - Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome N/A
Recruiting NCT02874586 - Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis N/A
Withdrawn NCT02878863 - Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis Phase 3